Professional Seasonal Analysis for Trading

KalVista Pharmaceuticals, Inc. - Common Stock (KALV)

Seasonality Analysis

Stocks 12 Years Analyzed

KalVista Pharmaceuticals, Inc. - Common Stock Annual Seasonality Statistics

18.77%
Avg Annual Return
46.6%
Avg Monthly Win Rate
8/12
Positive Months
12
Years Analyzed

KalVista Pharmaceuticals, Inc. - Common Stock Monthly Seasonality Performance

Month Avg Return Win Rate Strength
January -1.56%
55%
Weak
February BEST 8.05%
55%
Moderate
March -2.79%
55%
Weak
April 5.09%
50%
Weak
May 3.38%
55%
Moderate
June -4.61%
27%
Very Weak
July 0.91%
55%
Moderate
August 7.07%
45%
Weak
September WORST -8.80%
18%
Very Weak
October 2.23%
45%
Weak
November 5.94%
55%
Moderate
December 3.85%
45%
Weak

KalVista Pharmaceuticals, Inc. - Common Stock 2026 vs Historical Pattern

Current Position
100
Historical Avg Position
38.44
Deviation
+61.56
Performance
Significantly Above Average

KalVista Pharmaceuticals, Inc. - Common Stock Interactive Seasonality Chart

Interactive Seasonality Chart

Unlock the full interactive seasonality chart for KALV with overlay patterns, custom date ranges, and more.

Create Free Account

KalVista Pharmaceuticals, Inc. - Common Stock Pattern Scanner

Pattern Scanner

Discover recurring patterns, anomalies, and statistically frequent setups.

Create Free Account

KalVista Pharmaceuticals, Inc. - Common Stock Seasonal Historical Performance

Historical Performance

See historical average returns for KALV across multiple timeframes.

Create Free Account

About KalVista Pharmaceuticals, Inc. - Common Stock (KALV) Seasonality

KalVista Pharmaceuticals, Inc. - Common Stock (KALV) has been analyzed using 12 years of historical data to identify seasonal patterns. Classified under Stocks, KalVista Pharmaceuticals, Inc. - Common Stock shows distinct seasonal tendencies based on historical data.

The strongest month for KalVista Pharmaceuticals, Inc. - Common Stock is historically February, with an average return of 8.05% and a win rate of 55%. Conversely, September tends to be the weakest month, averaging -8.80% return.

Looking at the full calendar year, KalVista Pharmaceuticals, Inc. - Common Stock has an average annual return of 18.77% with an overall monthly win rate of 46.6%. Out of 12 months, 8 typically show positive average returns.

The seasonal pattern for KalVista Pharmaceuticals, Inc. - Common Stock has a consistency score of 29.3 (Poor), based on 12 years of data. Higher consistency means the seasonal pattern has been more reliable across different market conditions.

KalVista Pharmaceuticals, Inc. - Common Stock Seasonality FAQ

What is the best month to buy KalVista Pharmaceuticals, Inc. - Common Stock (KALV)?

Historically, February has been the best month for KalVista Pharmaceuticals, Inc. - Common Stock, with an average return of 8.05% and a win rate of 55%. However, past performance does not guarantee future results.

What is the worst month for KalVista Pharmaceuticals, Inc. - Common Stock (KALV)?

Based on historical data, September has been the weakest month for KalVista Pharmaceuticals, Inc. - Common Stock, with an average return of -8.80%. This is a historical observation and does not guarantee future results.

How reliable is KALV seasonality data?

The seasonality analysis for KalVista Pharmaceuticals, Inc. - Common Stock is based on 12 years of historical price data. While seasonal patterns can provide useful insights, they should be combined with other forms of analysis. Past patterns do not guarantee future performance.

How can I use KalVista Pharmaceuticals, Inc. - Common Stock seasonality in my trading?

Use KalVista Pharmaceuticals, Inc. - Common Stock (KALV) seasonality as one factor in your analysis. Identify historically strong and weak months, combine with other research methods. SeasOptima provides premium tools including interactive charts, pattern scanning, and historical performance data for deeper analysis.

More Stocks Seasonality Analysis

Statistical information based on historical data. Does not constitute investment advice or recommendation. Past performance does not guarantee future results.